Dicarbonyl and L-xylulose reductase (DCXR)

Dicarbonyl and L-xylulose reductase (DCXR) is a multifunctional enzyme encoded by the DCXR gene that primarily catalyzes the reduction of L-xylulose to xylitol, an important step in carbohydrate metabolism and the uronate pathway. DCXR also detoxifies reactive alpha-dicarbonyl compounds, thereby protecting cells from glycation and oxidative stress. It is highly expressed in kidney and liver, where it may contribute to cellular osmoregulation via xylitol production. DCXR exists in major and minor isoforms, with the major isoform being more catalytically active. Genetic deficiency of DCXR causes essential pentosuria, an inborn error of metabolism characterized by excessive urinary excretion of L-xylulose without associated health problems. DCXR also plays roles in sperm maturation and fertilization as a sperm surface protein. In pathological contexts, DCXR expression changes have been linked to several diseases, including male infertility, diabetes, nephropathy, and multiple cancers. Elevated DCXR levels, particularly in breast and prostate cancers, are associated with enhanced cell proliferation and glycolysis, implicating DCXR as an emerging oncogenic factor that could serve as a disease biomarker or future therapeutic target. Current research into DCXR’s disease roles and mechanistic contributions—especially in cancer metabolism and cell cycle regulation—suggests that modulation of its activity may have therapeutic potential, though direct pharmacologic targeting is not clinically established and safety considerations remain uncharacterized.

Other names

L-xylulose reductaseSDR20C1XRkiDCRKIDCRDCRHCR2P34HCarbonyl reductase IIDicarbonyl/L-xylulose reductaseKidney dicarbonyl reductaseShort-chain dehydrogenase/reductase family 20C member 1Sperm surface protein P34HHuman carbonyl reductase 2Epididymis secretory sperm binding protein

(Hypothetical, based on research models) Inhibition of DCXR expression or activity reduces glycolysis and cell proliferation in cancer cells.